Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol

BACKGROUND: Partial breast irradiation (PBI) is standard of care in low-risk breast cancer patients after breast-conserving surgery (BCS). Pre-operative PBI can result in tumor downstaging and more precise target definition possibly resulting in less treatment-related toxicity. This study aims to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Civil, Yasmin A., Oei, Arlene L., Duvivier, Katya M., Bijker, Nina, Meijnen, Philip, Donkers, Lorraine, Verheijen, Sonja, van Kesteren, Zdenko, Palacios, Miguel A., Schijf, Laura J., Barbé, Ellis, Konings, Inge R. H. M., -van der Houven van Oordt, C. Willemien Menke, Westhoff, Paulien G., Meijer, Hanneke J. M., Diepenhorst, Gwen M. P., Thijssen, Victor, Mouliere, Florent, Slotman, Berend J., van der Velde, Susanne, van den Bongard, H. J. G. Desirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169374/
https://www.ncbi.nlm.nih.gov/pubmed/37161377
http://dx.doi.org/10.1186/s12885-023-10910-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169374/
https://www.ncbi.nlm.nih.gov/pubmed/37161377
http://dx.doi.org/10.1186/s12885-023-10910-6

Ejemplares similares